EUVIMEDEUVIMED entdecken
Crossref

From the Editor-in-Chief: Biomedical Research and Biopharmaceutical Advances in Cuba

Keith L. Carson

BioProcessing Journal · 28.07.2026 · 3

DOI: 10.12665/j144.carson ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 28.07.2026. Verfasst von Keith L. Carson.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

European organizations have been doing business with Cuba during its last 30 years of biotechnology development, and have benefited from both licensing and distribution agreements for generic pharmaceuticals, as well as vaccines and other biologicals. However, as far as direct US/Cuban interactions, we’ll probably have to go through a period of “low-level” scientific exchanges before there is much interaction. As a starting point, it has been proposed by the American Association for the Advancement of Science (AAAS) that an official scientific and technology agreement be established to form a broader framework for interactions...

Zitieren

APA

Carson, K. L. (2026). From the Editor-in-Chief: Biomedical Research and Biopharmaceutical Advances in Cuba. BioProcessing Journal, 3. https://doi.org/10.12665/j144.carson

Vancouver

Carson KL. From the Editor-in-Chief: Biomedical Research and Biopharmaceutical Advances in Cuba. BioProcessing Journal. 2026:3. doi:10.12665/j144.carson

BibTeX
@article{Carson2026,
  author = {Carson, Keith L.},
  title = {From the Editor-in-Chief: Biomedical Research and Biopharmaceutical Advances in Cuba},
  journal = {BioProcessing Journal},
  year = {2026},
  pages = {3},
  doi = {10.12665/j144.carson}
}
Kostenlos starten →